Retraction: Myostatin Induces Degradation of Sarcomeric Proteins through a Smad3 Signaling Mechanism During Skeletal Muscle Wasting

The Endocrine Society - Tập 25 Số 11 - Trang 1936-1949 - 2011
Sudarsanareddy Lokireddy1, Craig McFarlane2, Xiaojia Ge1, Huoming Zhang1, Siu Kwan Sze1, Mridula Sharma3, Ravi Kambadur1,2
1School of Biological Sciences (S.L., X.G., H.Z., S.K.S., R.K.), Nanyang Technological University, Singapore 637551
2Singapore Institute for Clinical Sciences (A*STAR) (C.M., R.K.), Brenner Centre for Molecular Medicine, Singapore 117609
3Department of Biochemistry (M.S.), Yong Loo Lin School of Medicine, National University of Singapore, MD7, Singapore 117597

Tóm tắt

Từ khóa


Tài liệu tham khảo

Tisdale, 2009, Mechanisms of cancer cachexia., Physiol Rev, 89, 381, 10.1152/physrev.00016.2008

Evans, 2010, Skeletal muscle loss: cachexia, sarcopenia, and inactivity., Am J Clin Nutr, 91, 1123S, 10.3945/ajcn.2010.28608A

Csibi, 2009, MAFbx/Atrogin-1 controls the activity of the initiation factor eIF3-f in skeletal muscle atrophy by targeting multiple C-terminal lysines., J Biol Chem, 284, 4413, 10.1074/jbc.M807641200

Csibi, 2008, eIF3-f function in skeletal muscles: to stand at the crossroads of atrophy and hypertrophy., Cell Cycle, 7, 1698, 10.4161/cc.7.12.6090

Bodine, 2001, Identification of ubiquitin ligases required for skeletal muscle atrophy., Science, 294, 1704, 10.1126/science.1065874

Gomes, 2001, Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy., Proc Natl Acad Sci USA, 98, 14440, 10.1073/pnas.251541198

Clarke, 2007, The E3 Ligase MuRF1 degrades myosin heavy chain protein in dexamethasone-treated skeletal muscle., Cell Metab, 6, 376, 10.1016/j.cmet.2007.09.009

Cohen, 2009, During muscle atrophy, thick, but not thin, filament components are degraded by MuRF1-dependent ubiquitylation., J Cell Biol, 185, 1083, 10.1083/jcb.200901052

Krawiec, 2005, Hindlimb casting decreases muscle mass in part by proteasome-dependent proteolysis but independent of protein synthesis., Am J Physiol Endocrinol Metab, 289, E969, 10.1152/ajpendo.00126.2005

Schakman, 2009, Mechanisms of muscle atrophy induced by glucocorticoids., Horm Res, 72, 36, 10.1159/000229762

Testelmans, 2010, Atrophy and hypertrophy signaling in the diaphragm of patients with COPD., Eur Respir J, 35, 549, 10.1183/09031936.00091108

Chen, 2009, Upregulation of myostatin gene expression in streptozotocin-induced type 1 diabetes mice is attenuated by insulin., Biochem Biophys Res Commun, 388, 112, 10.1016/j.bbrc.2009.07.129

Léger, 2009, Atrogin-1, MuRF1, and FoXO, as well as phosphorylated GSK-3β and 4E-BP1 are reduced in skeletal muscle of chronic spinal cord-injured patients., Muscle Nerve, 40, 69, 10.1002/mus.21293

Mittal, 2010, The TWEAK-Fn14 system is a critical regulator of denervation-induced skeletal muscle atrophy in mice., J Cell Biol, 188, 833, 10.1083/jcb.200909117

Sandri, 2004, Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy., Cell, 117, 399, 10.1016/S0092-8674(04)00400-3

Latres, 2005, Insulin-like growth factor-1 (IGF-1) inversely regulates atrophy-induced genes via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway., J Biol Chem, 280, 2737, 10.1074/jbc.M407517200

Xu, 2000, The insulin-like growth factor-phosphatidylinositol 3-kinase-Akt signaling pathway regulates myogenin expression in normal myogenic cells but not in rhabdomyosarcoma-derived RD cells., J Biol Chem, 275, 36750, 10.1074/jbc.M005030200

McPherron, 1997, Double muscling in cattle due to mutations in the myostatin gene., Proc Natl Acad Sci USA, 94, 12457, 10.1073/pnas.94.23.12457

Kambadur, 1997, Mutations in myostatin (GDF8) in double-muscled Belgian Blue and Piedmontese cattle., Genome Res, 7, 910, 10.1101/gr.7.9.910

Schuelke, 2004, Myostatin mutation associated with gross muscle hypertrophy in a child., N Engl J Med, 350, 2682, 10.1056/NEJMoa040933

McPherron, 1997, Regulation of skeletal muscle mass in mice by a new TGF-β superfamily member., Nature, 387, 83, 10.1038/387083a0

Zimmers, 2002, Induction of cachexia in mice by systemically administered myostatin., Science, 296, 1486, 10.1126/science.1069525

Durieux, 2007, Ectopic expression of myostatin induces atrophy of adult skeletal muscle by decreasing muscle gene expression., Endocrinology, 148, 3140, 10.1210/en.2006-1500

McFarlane, 2006, Myostatin induces cachexia by activating the ubiquitin proteolytic system through an NF-κB-independent, FoxO1-dependent mechanism., J Cell Physiol, 209, 501, 10.1002/jcp.20757

Trendelenburg, 2009, Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size., Am J Physiol Cell Physiol, 296, C1258, 10.1152/ajpcell.00105.2009

Zhou, 2010, Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival., Cell, 142, 531, 10.1016/j.cell.2010.07.011

Lee, 2005, Regulation of muscle growth by multiple ligands signaling through activin type II receptors., Proc Natl Acad Sci USA, 102, 18117, 10.1073/pnas.0505996102

Walsh, 2007, Activin-type II receptor B (ACVR2B) and follistatin haplotype associations with muscle mass and strength in humans., J Appl Physiol, 102, 2142, 10.1152/japplphysiol.01322.2006

Amthor, 2004, Follistatin complexes myostatin and antagonises myostatin-mediated inhibition of myogenesis., Dev Biol, 270, 19, 10.1016/j.ydbio.2004.01.046

Tawa, 1997, Inhibitors of the proteasome reduce the accelerated proteolysis in atrophying rat skeletal muscles., J Clin Invest, 100, 197, 10.1172/JCI119513

Langley, 2002, Myostatin inhibits myoblast differentiation by down-regulating MyoD expression., J Biol Chem, 277, 49831, 10.1074/jbc.M204291200

Amirouche, 2009, Down-regulation of Akt/mammalian target of rapamycin signaling pathway in response to myostatin overexpression in skeletal muscle., Endocrinology, 150, 286, 10.1210/en.2008-0959

McFarlane, 2008, Myostatin is a procachectic growth factor during postnatal myogenesis., Curr Opin Clin Nutr Metab Care, 11, 422, 10.1097/MCO.0b013e32830007e2

Lagirand-Cantaloube, 2008, The initiation factor eIF3-f is a major target for atrogin1/MAFbx function in skeletal muscle atrophy., EMBO J, 27, 1266, 10.1038/emboj.2008.52

Lagirand-Cantaloube, 2009, Inhibition of atrogin-1/MAFbx mediated MyoD proteolysis prevents skeletal muscle atrophy in vivo., PLoS One, 4, e4973, 10.1371/journal.pone.0004973

Sartori, 2009, Smad2 and 3 transcription factors control muscle mass in adulthood., Am J Physiol Cell Physiol, 296, C1248, 10.1152/ajpcell.00104.2009

Amthor, 2002, The regulation and action of myostatin as a negative regulator of muscle development during avian embryogenesis., Dev Biol, 251, 241, 10.1006/dbio.2002.0812

Lee, 2001, Regulation of myostatin activity and muscle growth., Proc Natl Acad Sci USA, 98, 9306, 10.1073/pnas.151270098

Hill, 2002, The myostatin propeptide and the follistatin-related gene are inhibitory binding proteins of myostatin in normal serum., J Biol Chem, 277, 40735, 10.1074/jbc.M206379200

McCroskery, 2003, Myostatin negatively regulates satellite cell activation and self-renewal., J Cell Biol, 162, 1135, 10.1083/jcb.200207056

McFarlane, 2008, Myostatin signals through Pax7 to regulate satellite cell self-renewal., Exp Cell Res, 314, 317, 10.1016/j.yexcr.2007.09.012

Tsai, 2006, An optimized protocol for protein purification in cultured mammalian cells using a tandem affinity purification approach., Nat Protoc, 1, 2820, 10.1038/nprot.2006.371

Woodcock, 2009, A modified tandem affinity purification technique identifies that 14-3-3 proteins interact with Tiam1, an interaction which controls Tiam1 stability., J Proteome Res, 8, 5629, 10.1021/pr900716e

Bürckstümmer, 2006, An efficient tandem affinity purification procedure for interaction proteomics in mammalian cells., Nat Methods, 3, 1013, 10.1038/nmeth968

Driscoll, 1990, The proteasome (multicatalytic protease) is a component of the 1500-kDa proteolytic complex which degrades ubiquitin-conjugated proteins., J Biol Chem, 265, 4789, 10.1016/S0021-9258(19)34041-4

Hershko, 1988, Ubiquitin-mediated protein degradation., J Biol Chem, 263, 15237, 10.1016/S0021-9258(19)37575-1